Tsuda Tokutaro, Asanuma Yu, Koyama Shinichiro, Kawabata Yoshinori, Moriguchi Masato
Clinical Department of Internal Medicine, Jichi Medical School Omiya Medical Center, Saitama, Japan.
Am J Med Sci. 2007 Mar;333(3):185-90. doi: 10.1097/MAJ.0b013e318031b122.
The prognosis of interstitial pneumonia in patients with dermatomyositis is thought to depend on the histologic type and response to therapy. We report a case of hypomyopathic dermatomyositis with rapid development of a fatal interstitial pneumonia. Although the histology of lung biopsy indicated minimal alveolitis, the patient died despite multi-immunosuppressive therapy. The autopsy revealed acute and organizing diffuse alveolar damage. In this case, the lung biopsy taken before the acute deterioration did not predict the patient's poor prognosis. Interstitial pneumonia in patients with amyopathic or hypomyopathic dermatomyositis would develop rapidly progressive and refractory. We need larger and better prospective studies to determine whether early and intensive immunosuppressive therapy improves the prognosis of interstitial pneumonia in patients with amyopathic or hypomyopathic dermatomyositis.
皮肌炎患者间质性肺炎的预后被认为取决于组织学类型和对治疗的反应。我们报告一例低肌病性皮肌炎患者迅速发展为致命性间质性肺炎的病例。尽管肺活检的组织学显示肺泡炎轻微,但患者尽管接受了多种免疫抑制治疗仍死亡。尸检显示为急性和机化性弥漫性肺泡损伤。在该病例中,急性病情恶化前进行的肺活检未能预测患者的不良预后。无肌病性或低肌病性皮肌炎患者的间质性肺炎会迅速进展且难治。我们需要更大规模且更好的前瞻性研究来确定早期强化免疫抑制治疗是否能改善无肌病性或低肌病性皮肌炎患者间质性肺炎的预后。